Immune Responses in Health Care Personnel
NCT03323112 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-08-20
Summary
This is an investigator-initiated 10 year long open cohort observational study, aiming to increase the understanding of the humoral and cellular immunological mechanisms of vaccination against influenza, including effects of repeated vaccination, the duration of protection, immunity against circulating viruses, as well as factors affecting the immunological responses and immunity against other vaccine preventable infectious diseases among health care personnel.
Conditions
Interventions
- BIOLOGICAL
-
Vaccine for prevention of influenza. Vaccines change by influenza season.
Sponsors & Collaborators
-
Hospital District of Helsinki and Uusimaa
collaborator OTHER -
Finnish Institute for Health and Welfare
lead OTHER_GOV
Principal Investigators
-
Hanna Nohynek, MD, PhD · Finnish Institute for Health and Welfare
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-18
- Primary Completion
- 2027-10-14
- Completion
- 2027-10-14
Countries
- Finland
Study Locations
More Related Trials
-
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
NCT01191853 ·Status: COMPLETED
-
Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses
NCT06824779 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
NCT05108818 ·Status: RECRUITING ·Phase: PHASE4
-
Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine
NCT03748524 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Flu Infection at UPHS
NCT06807840 ·Status: RECRUITING
-
Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine
NCT00995527 ·Status: COMPLETED
-
Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
NCT04794829 ·Status: RECRUITING
-
Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults
NCT03160118 ·Status: COMPLETED ·Phase: PHASE4
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
Age and Response to Flu Vaccines
NCT03328325 ·Status: COMPLETED ·Phase: PHASE4
-
The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination
NCT02876159 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Response to Influenza Vaccination
NCT00551837 ·Status: COMPLETED
-
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines
NCT00776438 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Bone Marrow and Peripheral Blood Immune Responses Study
NCT05616546 ·Status: RECRUITING ·Phase: PHASE4
-
Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients
NCT01149382 ·Status: COMPLETED
-
Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects
NCT01422512 ·Status: COMPLETED ·Phase: PHASE3
-
Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response
NCT03701061 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT04579588 ·Status: RECRUITING
-
Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines
NCT01119157 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccination Among the Elderly Individuals
NCT02362919 ·Status: COMPLETED